Rare and unusual histological variants of prostatic carcinoma: Clinical significance

BJU International

Volumn 102, Issue 10, 2008, Pages 1369-1374

  Mazzucchelli, Roberta ^a   Lopez Beltran, Antonio ^b   Cheng, Liang ^c   Scarpelli, Marina ^a   Kirkali, Ziya ^d   Montironi, Rodolfo ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c INDIANA UNIVERSITY   (United States)

^d DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Carcinosarcoma; Ductal adenocarcinoma; Small cell carcinoma; Unusual carcinomas

Indexed keywords

ADENOCARCINOMA; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER MORPHOLOGY; CANCER RADIOTHERAPY; CARCINOSARCOMA; CLINICAL FEATURE; HISTOLOGY; HUMAN; IMMUNOPHENOTYPING; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; REVIEW; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; UROGENITAL TRACT TUMOR; UROTHELIAL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ACINAR CELL; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CARCINOSARCOMA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 54949132551     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08074.x     Document Type: Review

References (56)

1. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987 317 : 909 16
2. Epstein JI, Algaba F, Yang XJ et al. Tumours of the prostate. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA, Tumours of the Urinary System and Male Genital Organs, Chapter 3. Lyon : IARC Press, 2004 : 160 208
3. Abbas F, Civantos F, Benedetto P, Soloway MS. Small cell carcinoma of the bladder and prostate. Urology 1995 46 : 617 30
4. Amato RJ, Logothetis CJ, Hallinan R, Ro JY, Sella A, Dexeus FH. Chemotherapy for small cell carcinoma of prostate origin. J Urol 1992 147 : 935 7
5. Christopher ME, Seftel AD, Sorenson K, Resnick MI. Small cell carcinoma of the genitourinary tract: an immunohistochemical, electron microscopic and clinicopathological study. J Urol 1991 146 : 382 8
6. Di Sant'Agnese PA. Divergent neuroendocrine differentiation in prostatic carcinoma. Semin Diagn Pathol 2000 17 : 149 61
7. Evans AJ, Humphrey PA, Belani J, van der Kwast TH, Srigley JR. Large cell neuroendocrine carcinoma of the prostate. A clinicopathologic summary of 7 cases of a rare manifestation of advance prostate cancer. Am J Surg Pathol 2006 30 : 684 93
8. Helpap B, Kollermann J. Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis. Virchows Arch 1999 434 : 385 91
9. Hindson DA, Knight LL, Ocker JM. Small-cell carcinoma of prostate. Transient complete remission with chemotherapy. Urology 1985 26 : 182 4
10. Huang J, Wu C, di Sant'Agnese PA, Yao JL, Cheng L, Na Y. Function and molecular mechanisms of neuroendocrine cells in prostate cancer. Anal Quant Cytol Histol 2007 29 : 128 38
11. Losi L, Di Gregori C, Brausi M, Fante R, Hurlimann J. Expression of p53 protein in prostate cancers of different histologic types. Pathol Res Pract 1994 190 : 384 8
12. Mackey JR, Au H-J, Hugh J, Venner P. Genitourinary small cell carcinoma. Determination of clinical and therapeutic factors associated with survival. J Urol 1998 159 : 1624 9
13. Oesterling JE, Hanzeur CG, Farrow GM. Small cell anaplastic carcinoma in clinical, pathological, and immunological study of 27 patients. J Urol 1992 147 : 804 7
14. Papandreou CN, Daliani DD, Thall PF et al. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small cell carcinoma of the prostate. Am J Surg Pathol 2002 20 : 3072 80
15. Schwartz LH, Latrenta LR, Bonaccio E, Kelly WK, Scher HI, Panicek DM. Small cell and anaplastic prostate cancer-correlation between CT findings and prostate-specific antigen level. Radiology 1998 208 : 735 8
16. Têtu B, Ro JY, Ayala AB, Johnson DE, Logothetis CJ, Ordonez NG. Small cell carcinoma of the prostate. Part 1. A clinicopathologic study of 20 cases. Cancer 1987 59 : 1803 9
17. Wang W, Epstein JI. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases. Am J Surg Pathol 2008 32 : 65 71
18. Yao JL, Huang J, di Sant'Agnese PA. Small cell carcinoma of the prostate. Diagn Histopathol 2008 14 : 117 21
19. Bock BJ, Bostwick DG. Does prostatic ductal adenocarcinoma exist? Am J Surg Pathol 1999 23 : 781 5
20. Bostwick DG, Kindrachuk RW, Rouse RV. Prostatic adenocarcinoma with endometrioid features. Clinical, pathologic, and ultrastructural findings. Am J Surg Pathol 1985 9 : 595 609
21. Brinker DA, Potter SR, Epstein JI. Ductal adenocarcinoma of the prostate diagnosed on needle biopsy. Correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol 1999 23 : 1471 9
22. Christensen WN, Steinberg G, Walsh PC, Epstein JI. Prostatic duct adenocarcinoma. Findings at radical prostatectomy. Cancer 1991 67 : 2118 24
23. Dube VE, Farrow GM, Greene LF. Prostatic adenocarcinoma of ductal origin. Cancer 1973 32 : 402 9
24. Epstein JI, Woodruff JM. Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunnohistochemical study of ten cases. Cancer 1986 57 : 111 9
25. Kelemen K, Adley B, Yang XJ, Wang HL, Humphrey PA. Ductal adenocarcinoma of the prostate. A clinicopathologic study of 50 cases. Lab Invest 2006 86 : 144A
26. Lemberger RJ, Bishop MC, Bates CP, Blundell W, Ansell ID. Carcinoma of the prostate of ductal origin. Br J Urol 1984 56 : 706 9
27. Millar EKA, Sharma NK, Lessels AM. Ductal (endometrioid) adenocarcinoma of the prostate: a clinicopathological study of 16 cases. Histopathology 1996 29 : 11 9
28. Ro JY, Ayala AG, Wishnow KI, Ordoñez NG. Prostatic duct adenocarcinoma with endometrioid features. Immunohistochemical and electron microscopic study. Semin Diagn Pathol 1988 5 : 301 11
29. Tannenbaum M. Histopathology of the prostate gland. In Tannenbaum M, Urologic Pathology: The Prostate. Philadelphia : Lea & Febiger, 1977 : 312 5
30. Epstein JI, Allsbrook WC Amin MB et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 2005 29 : 1228 42
31. Adley BP, Yang XJ. Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review. Anal Quant Cytol Histol 2006 28 : 1 13
32. Samaratunga H, Singh M. Distribution pattern of basal cells detected by cytokeratin 34 Beta E12 in primary prostatic duct adenocarcinoma. Am J Surg Pathol 1997 21 : 435 40
33. Beach R, Gown AM, De Peralta-Venturina MN et al. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol 2002 26 : 1588 96
34. Dundore PA, Cheville CJ, Nascimento AG, Farrow GM, Bostwick DG. Carcinosarcoma of the prostate. Report of 21 cases. Cancer 1995 76 : 1035 42
35. Shannon RL, Ro JY, Grignon DJ et al. Sarcomatoid carcinoma of the prostate. A clinicopathologic study of 12 patients. Cancer 1992 69 : 2676 82
36. Ray ME, Wojno KJ, Goldstein KJ, Olson KB, Shah RB, Cooney KA. Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the prostate. Urology 2006 67 : 423e5 423e8
37. Delahunt B, Eble JN, Nacey JN, Grebe SK. Sarcomatoid carcinoma of the prostate: progression from adenocarcinoma associated with p53 over-expression. Anticancer Res 1999 19 : 4279 83
38. Poblet E, Gomez-Tierno A, Alfaro L. Prostatic carcinosarcoma: a case originating in a previous ductal adenocarcinoma of the prostate. Pathol Res Pract 2000 196 : 569 72
39. Berney DM, Ravi R, Baithun SI. Prostatic carcinosarcoma with squamous cell differentiation: a consequence of hormonal therapy. Report of two cases and review of the literature. J Urol Pathol 1979 11 : 123 32
40. Rogers CG, Parwani A, Tekes A, Schoenberg MP, Epstein JI. Carcinosarcoma of the prostate with urothelial and squamous components. J Urol 2005 173 : 439 40
41. Wick MR, Young RH, Malvesta R, Beebe DS, Hansen JJ, Dehner LP. Prostatic carcinosarcomas. Clinical, histologic, and immunohistochemical data on two cases, with a review of the literature. Am J Clin Pathol 1989 92 : 131 9
42. Iczkowski KA, Ferguson KL, Grier DD et al. Adenoid cystic/basal cell carcinoma of the prostate. Am J Surg Pathol 2003 27 : 1523 9
43. Mastropasqua MG, Pruneri G, Renne G, De Cobelli O, Viale G. Basaloid cell carcinoma of the prostate. Virchows Arch 2003 443 : 787 91
44. Montironi R, Mazzucchelli R, Stramazzotti D, Scarpelli M, Lopez-Beltran A, Bostwick DG. Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB2 expression. J Clin Pathol 2005 58 : 290 6
45. Zhou M, Magi-Galluzzi C, Epstein JI. Prostate basal cell lesions can be negative for basal cell keratins: a diagnostic pitfall. Anal Quant Cytol Histol 2006 28 : 125 9
46. Little NA, Wiener JS, Walther PJ, Paulson DF, Anderson EE. Squamous cell carcinoma of the prostate: 2 cases of a rare malignancy and review of the literature. J Urol 1993 149 : 137 9
47. Mohan H, Bal A, Punia RPS, Bawa AS. Squamous cell carcinoma of the prostate. Int J Urol 2003 10 : 114 6
48. Parwani AV, Kronz JD, Genega EM, Gaudin P, Chang S, Epstein JI. Prostate carcinoma with squamous differentiation: an analysis of 33 cases. Am J Surg Pathol 2004 28 : 651 7
49. Wernert N, Goebbels R, Bonkhoff H, Dhom G. Squamous cell carcinoma of the prostate. Histopathology 1990 17 : 339 44
50. Bennett RS, Edgerton EO. Mixed prostatic carcinoma. J Urol 1973 110 : 561 3
51. Cheville JC. Urothelial carcinoma of the prostate. An immunohistochemical comparison with high grade prostatic adenocarcinoma and review of the literature. J Urol Pathol 1998 9 : 141 54
52. Cheville JC, Dundore PA, Bostwick DG et al. Transitional cell carcinoma of the prostate. Clinicopathologic study of 50 cases. Cancer 1998 82 : 703 7
53. Goebbels R, Amberger L, Wernert N, Dhom G. Urothelial carcinoma of the prostate. Appl Pathol 1985 3 : 242 54
54. Oliai BR, Kahane H, Epstein JI. A clinicopathologic analysis of urothelial carcinomas diagnosed in prostate needle biopsy. Am J Surg Pathol 2001 25 : 794 801
55. Nixon RG, Chang SS, Lafleur BJ, Smith JA, Cookson MS. Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder. J Urol 2002 167 : 502 5
56. Greene FL, Page DL, Fleming ID et al. Urethra. In Greene FL, Page DL, Fleming ID et al., AJCC Cancer Staging Manual, 6th edn. New York : Springer Verlag, 2002 : 341 3